Study of XL418 in Adults With Solid Tumors
NCT00460278
·
clinicaltrials.gov ↗
PHASE1
Phase
SUSPENDED
Status
63
Enrollment
INDUSTRY
Sponsor class
Stopped
Enrollment suspended due to low drug exposure.
Conditions
Cancer
Solid Tumors
Interventions
DRUG:
XL418
Sponsor
Exelixis